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The catalytic subunit of CAMP-dependent protein kinases was localized in microtubules and neurotilaments by immunogold electron microscopy. 
In microtubules, the label was similarly distributed as an immunolabel for the microtubule associated protein MAP 2. The neurofilaments showed 
no reaction with the MAP 2-antiserum. Our results support the suggestion of an in vivo role of CAMP-dependent protein kinases in the regulation 
of microtubules. In addition, this is the first demonstration that CAMP-dependent protein kinase is associated with neurofilaments. 
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1. INTRODUCTION 
Cyclic AMP-dependent protein kinases have been 
shown to be involved in learning and memory [1,2]. 
However, only little is known on the crucial cellular 
targets of these enzymes in these processes. One attrac- 
tive hypothesis is that the dynamic structure of the 
cytoskeleton, which is controlled by phosphoryla- 
tion/dephosphorylation, is a substrate for functional 
plasticity of the central nervous system (cf. [3]). 
The microtubule associated protein MAP 2 is one of 
the major in vitro substrates of brain CAMP-dependent 
protein kineases [4] and a considerable portion of the 
enzyme co-purifies with MAP 2 [5]. A physiological 
significance of this type of kinase in microtubule 
phosphorylation is suggested also from im- 
munocytochemical colocalization of MAP 2 and the 
regulatory subunit RI1 of CAMP-dependent protein 
kinases in neurons [6,7]. An in situ localization of the 
catalytic subunit C, the enzymatic active subunit of the 
kinases, in brain microtubules has not been reported 
yet. 
The significance of CAMP in the phosphorylation of 
neurofilaments is unclear. A protein kinase which 
copurifies with neurofilament preparations is CAMP- 
independent and CAMP added to such preparations 
showed no significant effect on endogenous protein 
phosphorylation [&lo]. Recent phosphopeptide 
analyses of in vitro and in vivo phosphorylated 
neurofilaments [11,12], however, suggest a role of 
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CAMP-dependent protein kinases also in neurofilament 
phosphorylation. These kinases could originate from 
the cytosol or from other cellular structures. Previous- 
ly, it has been reported that neurofilament preparations 
free of CAMP-dependent protein kinase activity could 
be phosphorylated in a CAMP-dependent manner by 
the addition of microtubules purified by cycles of 
assembly and dissassembly [13]. Since a large number 
of morphological, biochemical and biophysical data 
suggests MAP-mediated interactions between 
neurofilaments and microtubules, one could assume 
that CAMP-dependent phosphorylation of 
neurofilaments is mediated by the MAP-associated pro- 
tein kinase. 
In this study, we have performed an immunoelectron 
microscopical ocalization of the C-subunit in rat brain 
slices. Our results show that CAMP-dependent protein 
kinases are associated with microtubules as well as with 
neurofilaments. 
2. MATERIALS AND METHODS 
Antiserum against the C-subunit of CAMP-dependent protein 
kinases from bovine heart was produced and characterized as describ- 
ed [14]. Anti-MAP 2 serum was purchased from Sigma (Deisenhofen, 
Germany) and Protein A-gold from Janssen (Beerse, Belgium). 
Male Wistar rats (170-220 g) were anaesthetized with pentobarbital 
(60 mg/kg) and brain tissue fixed by vascular perfusion with 1.25% 
glutaraldhyde. After dehydration, tissue pieces were embedded in 
Lowicryl K4M [15]. Immunocytochemistry was performed as describ- 
ed previously 1161 with the antisera used at a dilution of 1:2000 (anti- 
C-subunit) or undiluted (anti-MAP 2). Protein A labelled with 15 nm 
gold was used at a dilution of 1:lO. The immunolabelled thin sections 
were stained with uranylacetate and lead citrate and observed and 
photographed in a Zeiss EM 9 S-2 electron microscope. 
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Fig. i. Immunolocaiizat~on f the catalytic subunit of carp-dependent protein kinases at ne~rofilaments (a-c) and microtubules (d-f). (Panels, 
a,d) Anti-catalytic subunit serum. (Panels b,e) Anti-MAP 2 serum. (Panels c,f) Preimmune serum. Bar=@.2 Frn. 
168 
3. RESULTS 
The immunocytochemical procedure which led to an 
optimal preservation of the antigenicity of CAMP- 
dependent protein kinase resulted in some loss in the 
ultrastructural quality. Nevertheless, microtubules as 
well as neurofilaments could be clearly identified by 
their size as well as by their typical forms. 
Neurofilaments were visible in myelinized axons as 
relatively thin (diameter lo-15 nm) filaments which 
were arranged in a characteristic wavy way (Fig. la-c; 
Fig. 2a). Microtubules showed the typical paraIle1 ar- 
rangement of larger-sized (diameter 20-30 nm) 
monomers (Fig. Id-f; Fig. 2b). Both types of 
cytoskeletal components showed also typical 
crossbridges between single elements (Fig. I; Fig. 2, ar- 
row). Microtubules (Fig. le) but not neurofilaments 
(Fig. lb) showed an immunoreaction with antiserum 
against MAP-2. Incubation with the well-characterized 
[14,16] antiserum against the C-subunit of CAMP- 
dependent protein kinases led to specific immunolabell- 
ing of both, microtubules and neurofilaments (Fig. 
la,d; Fig. 2). In microtubules, the distribution of the 
label was similar to that of the label for MAP-2 (Fig. 
ld,e). In both types of neurofibrils, the majority of gold 
particles was found at the monomers and not on the 
crossbridges between them (Fig. la,d; Fig. 2). The 
results were identical with tissues from 3 different rats. 
Controls, performed by replacement of the antiserum 
with preimmune serum (Fig. lc,f), by omission of an- 
tiserum, by preincubation of the protein A-gold solu- 
tion with anti-C serum before use and by preincubation 
of thin sections with unlabelled protein A before the in- 
cubation step with protein A gold (not shown) led to an 
almost complete abolition of immunolabelling. 
4. DISCUSSION 
The in situ localization of C-subunit immunoreactivi- 
ty in microtubules agrees well with previous resufts of 
biochemical investigations [S] which suggest that the 
CAMP-dependent protein kinase is associated with 
MAP-2. The distribution of the immunolabel is also in 
accordance with recent results [17] on the sequence of 
mouse brain MAP 2. Recognition sites for CAMP- 
dependent phosphorylation are located at the C- 
terminal part of the molecule which is thought to be 
clustered near the microtubule binding domain [17]. 
The presence of C-subunit immunoreactivity in 
neurofilaments together with the absence of 
MAP-2-immunoreactivity suggests that neurofilaments 
can be directly phosphorylated by CAMP-dependent 
protein kinases and not only by interaction with MAP-2 
associated CAMP-dependent protein kinase. Previous- 
ly, we had immunolocalized the C-subunit also in 
keratin filaments of parotid gland duct cells, another 
type of intermediate filaments [16]. Experiments per- 
formed in vitro with vimentin [18], desmin [I91 and 
neurofilaments f20] as well as with nerve cell 
microtubules [21] suggest that the CAMP-dependent 
protein kinases are involved in filament assembly. The 
consequences of such phosphorylations for behavioral 
functions are yet unknown. The present results, 
however, raise the question whether neurodegenerative 
diseases like Alzheimer’s disease which are characteriz- 
ed by the occurrence of neuro~brillary tangles and by 
an abnormal distribution and concentration of protein 
kinase C [22] and casein kinase II [23] in brain cells, 
have also aberrant CAMP-dependent protein kinases. 
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